Rational design of stable lyophilized protein formulations: theory and practice.
about
Advanced protein formulationsCharacterizing Protein Structure, Dynamics and Conformation in Lyophilized SolidsThe Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for ProductionMass spectrometric approaches to study protein structure and interactions in lyophilized powders.Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.Protection of lactoperoxidase activity with sugars during lyophilization and evaluation of its antibacterial properties.Adsorbing/dissolving Lyoprotectant Matrix Technology for Non-cryogenic Storage of Archival Human SeraEffects of glycosylation on the stability of protein pharmaceuticals.Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and in vivo bioavailability.Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.Preliminary Assessment of Various Additives on the Specific Reactivity of Anti- rHBsAg Monoclonal Antibodies.Predicting protein aggregation during storage in lyophilized solids using solid state amide hydrogen/deuterium exchange with mass spectrometric analysis (ssHDX-MS)Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization.Freeze-drying of mammalian cells using trehalose: preservation of DNA integrity.Second International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.Cloning and Expression of Recombinant Chondroitinase ACII and Its Comparison to the Arthrobacter aurescens Enzyme.Different Structural Conformers of Monomeric α-Synuclein Identified after Lyophilizing and Freezing
P2860
Q26822616-FC533803-0D44-493F-9726-2BCD63C9E595Q28081973-975D034A-6857-46CD-8274-B551517F6B3CQ28554493-FB20F0E2-E5A7-46E7-B0AB-4F8827A9E7FAQ30374347-A254D188-717A-46A5-A027-59E9D7146374Q34581175-25FB32E4-AB31-4A2F-9B9F-E22A8FC23DE9Q36096893-AF923DAE-B8F3-46F7-B250-28BDEDB9AA1EQ36789976-FB27EF45-BC88-4C7C-AC20-CA9C910E0CB3Q37114305-64318F1C-6681-45FE-8E3C-C59480CCF684Q37194634-E394D082-02E9-4892-96CE-70EEB21FD3B4Q40244595-81CF6924-AE28-4D42-8190-6E7E4442DE5DQ40277511-B93AD8E8-8596-4E5B-84A8-2E2BC311DB39Q40505241-A75D8D15-539E-4461-A547-4D2181544519Q41032094-FAA619A1-C266-4654-A16C-C6367620FC14Q41108513-6826A7D2-A2A6-46DC-B464-B1942B19FEDFQ43070193-72AF3E00-1FF2-4CD5-A988-5D4DAE3E7DB9Q47805731-4F052D70-7896-4646-86F2-5C001D0A2096Q57948233-8AA5FDD6-2BF9-46C2-B994-350A037F0B27
P2860
Rational design of stable lyophilized protein formulations: theory and practice.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Rational design of stable lyophilized protein formulations: theory and practice.
@ast
Rational design of stable lyophilized protein formulations: theory and practice.
@en
Rational design of stable lyophilized protein formulations: theory and practice.
@nl
type
label
Rational design of stable lyophilized protein formulations: theory and practice.
@ast
Rational design of stable lyophilized protein formulations: theory and practice.
@en
Rational design of stable lyophilized protein formulations: theory and practice.
@nl
prefLabel
Rational design of stable lyophilized protein formulations: theory and practice.
@ast
Rational design of stable lyophilized protein formulations: theory and practice.
@en
Rational design of stable lyophilized protein formulations: theory and practice.
@nl
P2093
P1476
Rational design of stable lyophilized protein formulations: theory and practice
@en
P2093
Beyong S Chang
John F Carpenter
William Garzon-Rodriguez
P304
P356
10.1007/978-1-4615-0557-0_5
P577
2002-01-01T00:00:00Z